These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14713712)

  • 21. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
    Belghith M; Bluestone JA; Barriot S; Mégret J; Bach JF; Chatenoud L
    Nat Med; 2003 Sep; 9(9):1202-8. PubMed ID: 12937416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regulatory T cells].
    Oida T; Sakaguchi S
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():154-8. PubMed ID: 15861650
    [No Abstract]   [Full Text] [Related]  

  • 24. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?
    Shevach EM; Stephens GL
    Nat Rev Immunol; 2006 Aug; 6(8):613-8. PubMed ID: 16868552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
    Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.
    Andersson J; Boasso A; Nilsson J; Zhang R; Shire NJ; Lindback S; Shearer GM; Chougnet CA
    J Immunol; 2005 Mar; 174(6):3143-7. PubMed ID: 15749840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficiency of mouse CD4+CD25+Foxp3+ regulatory T cells in xenogeneic pig thymus-grafted nude mice suffering from autoimmune diseases.
    Zhang B; Sun C; Qu Y; Zhang A; Liu J; Zhang L; Niu Z; Zhao Y
    Cell Mol Immunol; 2008 Oct; 5(5):325-32. PubMed ID: 18954555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
    Mukherjee S; Maiti PK; Nandi D
    J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural regulatory CD4 T cells expressing CD25.
    Papiernik M; Banz A
    Microbes Infect; 2001 Sep; 3(11):937-45. PubMed ID: 11564442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of immune homeostasis by naturally arising regulatory CD4+ T cells.
    Gavin M; Rudensky A
    Curr Opin Immunol; 2003 Dec; 15(6):690-6. PubMed ID: 14630204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric analysis of expression of transforming growth factor-beta and glucocorticoid-induced tumor necrosis factor receptor on CD4(+) CD25(+) T cells of patients with inflammatory bowel disease.
    Ikeda M; Takeshima F; Ohba K; Ohnita K; Isomoto H; Yamakawa M; Omagari K; Mizuta Y; Kohno S
    Dig Dis Sci; 2006 Jan; 51(1):178-84. PubMed ID: 16416233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD137: costimulator turns suppressor?
    Al-Shamkhani A
    Immunology; 2004 Sep; 113(1):23-5. PubMed ID: 15312132
    [No Abstract]   [Full Text] [Related]  

  • 35. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function.
    Tang Q; Boden EK; Henriksen KJ; Bour-Jordan H; Bi M; Bluestone JA
    Eur J Immunol; 2004 Nov; 34(11):2996-3005. PubMed ID: 15468055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.
    Tsaknaridis L; Spencer L; Culbertson N; Hicks K; LaTocha D; Chou YK; Whitham RH; Bakke A; Jones RE; Offner H; Bourdette DN; Vandenbark AA
    J Neurosci Res; 2003 Oct; 74(2):296-308. PubMed ID: 14515359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory T cells in the control of immune pathology.
    Maloy KJ; Powrie F
    Nat Immunol; 2001 Sep; 2(9):816-22. PubMed ID: 11526392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations.
    Ronchetti S; Zollo O; Bruscoli S; Agostini M; Bianchini R; Nocentini G; Ayroldi E; Riccardi C
    Eur J Immunol; 2004 Mar; 34(3):613-622. PubMed ID: 14991590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype.
    Kemper C; Chan AC; Green JM; Brett KA; Murphy KM; Atkinson JP
    Nature; 2003 Jan; 421(6921):388-92. PubMed ID: 12540904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.